Facebook Linkedin Twitter
Inside Precision Medicine Alnylam’s Vutrisiran Gets Good Results for Cardiac Amyloidosis

Amyloidosis

Image of a heart with a DNA double helix in front of it to indicate cardiovascular disease and the impact of transthyretin amyloid cardiomyopathy (ATTR-CM) which can be treated with vutrisiran.
News & Features

Alnylam’s Vutrisiran Gets Good Results for Cardiac Amyloidosis

0
AI Brain Concept
News & Features

Beginning a New Era of Precision Alzheimer’s Therapeutics

Helen Albert
0
3d illustration of the human brain with visible blood vessels illustrating Alzheimer's disease and dementia.
News & Features

Fluorescent Test Lights up Amyloids to Diagnose Alzheimer’s, Parkinson’s, and More

0
Angled DNA Double Helix
News & Features

One and Done? How CRISPR Is Changing the Clinical Outlook for Multiple Diseases

Laura Cowen
0
Image showing bacteria next to blood cells in a blood vessel to illustrate what happens prior to sepsis setting in
Molecular Dx

Hospital-Treated Infections Linked with Later Alzheimer’s and Parkinson’s

0
Alzheimer's disease: illustration of the amyloid-beta 40 peptide (and others) accumulating to form amyloid fibrils that build up dense amyloid plaques.
News & Features

Attralus Shows Promise in Tackling Systemic Amyloidosis

0
3d illustration of a part of an RNA chain to illustrate new RNA therapeutics
Molecular Dx

Alnylam Gets FDA Backing for Second Generation Onpattro Competitor

0
Coronavirus RNA strand
News & Features

Intellia Acquires Rewrite in Deal Worth Up to $200M

0
CRISPR technology
News & Features

First Positive Data of In Vivo CRISPR-Based Genome Editing in Humans Reported

0

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine